Cargando…

Assessing genomic sequencing information for health care decision making : workshop summary /

"Rapid advances in technology have lowered the cost of sequencing an individual's genome from the several billion dollars that it cost a decade ago to just a few thousand dollars today and have correspondingly greatly expanded the use of genomic information in medicine. Because of the lack...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Assessing Genomic Sequencing Information for Health Care Decision Making (Workshop) Washington, D.C.) (Autor)
Otros Autores: Beachy, Sarah H. (rapporteur.), Johnson, Samuel G. (rapporteur.), Olson, Steve, 1956- (rapporteur.), Berger, Adam C. (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, [2014]
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn888201733
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |||||||||||
008 140821s2014 dcua ob 100 0 eng d
040 |a MMU  |b eng  |e rda  |e pn  |c MMU  |d E7B  |d CUS  |d YDXCP  |d N$T  |d OCLCF  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d EBLCP  |d DEBSZ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d VT2  |d AGLDB  |d MOR  |d ZCU  |d MERUC  |d OCLCQ  |d MERER  |d OCLCQ  |d OCLCO  |d U3W  |d BUF  |d STF  |d VNS  |d VTS  |d COCUF  |d EZ9  |d ICG  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCA  |d LVT  |d OCLCA  |d CUY  |d TKN  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCL  |d OCLCQ  |d K6U  |d OCLCA  |d UKAHL  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCA  |d OCL  |d OCLCA  |d OCLCO  |d OCLCL 
019 |a 923291086  |a 1055344112  |a 1066570234  |a 1081185970  |a 1229859413 
020 |a 9780309304955  |q (electronic bk.) 
020 |a 0309304954  |q (electronic bk.) 
020 |z 9780309304948  |q (paperback) 
020 |z 0309304946  |q (paperback) 
029 1 |a DEBBG  |b BV042795508 
029 1 |a DEBBG  |b BV044056170 
029 1 |a DEBSZ  |b 446457175 
029 1 |a DEBSZ  |b 452582202 
029 1 |a GBVCP  |b 836997921 
035 |a (OCoLC)888201733  |z (OCoLC)923291086  |z (OCoLC)1055344112  |z (OCoLC)1066570234  |z (OCoLC)1081185970  |z (OCoLC)1229859413 
050 4 |a RB155 
060 4 |a QZ 52 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616/.042  |2 23 
049 |a UAMI 
111 2 |a Assessing Genomic Sequencing Information for Health Care Decision Making (Workshop)  |d (2014 :  |c Washington, D.C.).  |e author. 
245 1 0 |a Assessing genomic sequencing information for health care decision making :  |b workshop summary /  |c Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy ; Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger, and Steve Olson, rapporteurs ; Institute of Medicine of the National Academies. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource (xx, 105 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a "Rapid advances in technology have lowered the cost of sequencing an individual's genome from the several billion dollars that it cost a decade ago to just a few thousand dollars today and have correspondingly greatly expanded the use of genomic information in medicine. Because of the lack of evidence available for assessing variants, evaluation bodies have made only a few recommendations for the use of genetic tests in health care. For example, organizations, such as the Evaluation of Genomic Applications in Practice and Prevention working group, have sought to set standards for the kinds of evaluations needed to make population-level health decisions. However, due to insufficient evidence, it has been challenging to recommend the use of a genetic test. An additional challenge to using large-scale sequencing in the clinic is that it may uncover "secondary," or "incidental," findings - genetic variants that have been associated with a disease but that are not necessarily related to the conditions that led to the decision to use genomic testing. Furthermore, as more genetic variants are associated with diseases, new information becomes available about genomic tests performed previously, which raises issues about how and whether to return this information to physicians and patients and also about who is responsible for the information. To help develop a better understanding of how genomic information is used for healthcare decision making, the Roundtable on Translating Genomic-Based Research for Health of the Institute of Medicine held a workshop in Washington, DC in February 2014. Stakeholders, including clinicians, researchers, patients, and government officials, discussed the issues related to the use of genomic information in medical practice. Assessing Genomic Sequencing Information for Health Care Decision Making is the summary of that workshop. This report compares and contrasts evidence evaluation processes for different clinical indications and discusses key challenges in the evidence evaluation process"--Publisher's description 
588 0 |a Online resource; title from resource home page (National Academies Press, viewed August 21, 2014). 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- How evidence is gathered and evaluated -- Patient care and health decisions -- The development of practice guidelines -- How insurers decide whether to pay for testing -- Addressing challenges. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Medical genetics  |x Social aspects  |v Congresses. 
650 0 |a Genomics  |v Congresses. 
650 0 |a Genetic epidemiology  |v Congresses. 
650 0 |a Genetic screening. 
650 0 |a Genomics. 
650 0 |a Decision making. 
650 0 |a Medical care. 
650 0 |a Medical genetics. 
650 0 |a Precision medicine. 
650 1 2 |a Genetic Testing 
650 1 2 |a Genomics 
650 2 2 |a Decision Making 
650 2 2 |a Delivery of Health Care 
650 2 2 |a Genetics, Medical 
650 2 2 |a Precision Medicine 
650 2 |a Patient Care 
650 6 |a Génétique médicale  |x Aspect social  |v Congrès. 
650 6 |a Génomique  |v Congrès. 
650 6 |a Épidémiologie génétique  |v Congrès. 
650 6 |a Dépistage génétique. 
650 6 |a Génomique. 
650 6 |a Prise de décision. 
650 6 |a Prestation de soins. 
650 6 |a Génétique médicale. 
650 6 |a Médecine de précision. 
650 6 |a Soins médicaux. 
650 7 |a decision making.  |2 aat 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Precision medicine  |2 fast 
650 7 |a Medical genetics  |2 fast 
650 7 |a Medical care  |2 fast 
650 7 |a Genetic screening  |2 fast 
650 7 |a Decision making  |2 fast 
650 7 |a Genetic epidemiology  |2 fast 
650 7 |a Genomics  |2 fast 
650 7 |a Medical genetics  |x Social aspects  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Beachy, Sarah H.,  |e rapporteur. 
700 1 |a Johnson, Samuel G.,  |e rapporteur. 
700 1 |a Olson, Steve,  |d 1956-  |e rapporteur.  |1 https://id.oclc.org/worldcat/entity/E39PBJpV6yX9jFKMQMYFvVkhpP 
700 1 |a Berger, Adam C.,  |e rapporteur. 
710 2 |a Institute of Medicine (U.S.).  |b Roundtable on Translating Genomic-Based Research for Health,  |e issuing body. 
758 |i has work:  |a Assessing genomic sequencing information for health care decision making (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCH7bg6B6HMWck4Pp7fx343  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Assessing Genomic Sequencing Information for Health Care Decision Making (Workshop) (2014 : Washington, D.C.).  |t Assessing genomic sequencing information for health care decision making.  |d Washington, D.C. : National Academies Press, 2014  |z 9780309304948  |z 0309304946 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379357  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617935 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3379357 
938 |a ebrary  |b EBRY  |n ebr10924436 
938 |a EBSCOhost  |b EBSC  |n 867724 
938 |a YBP Library Services  |b YANK  |n 12061047 
994 |a 92  |b IZTAP